TScan Therapeutics
TCRX
TCRX
25 hedge funds and large institutions have $26.3M invested in TScan Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 8 closing their positions.
Holders
25
Holders Change
-4
Holders Change %
-13.79%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CCM
26
CAAS Capital Management
New York
| – | – | -25,633 | Closed |
|
|
HF
27
HRT Financial
New York
| – | – | -20,829 | Closed |
|
28
LPL Financial
San Diego,
California
| – | – | -13,000 | Closed |
|
29
Millennium Management
New York
| – | – | -12,276 | Closed |
|
30
Jane Street
New York
| – | – | -11,307 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | – | -811 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | – | -189 | Closed |
|
|
CFGS
33
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
34
Wells Fargo
San Francisco,
California
| $0 | 41 | – | – |
|